Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from ...

Street Target: ~$31__Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)__ >>> What Happened?Hims & Hers Health (HIMS) has barely moved ...

Hims & Hers Health trades at $29.13 today, down 0.21%. Legal risks from an FTC lawsuit could impact sentiment and volatility.

Hims argued that the agency ignored the company’s disclosures and misapplied federal law on subscriptions and privacy.

USCB Financial Holdings (USCB) reported third-quarter 2026 net income of $9.5 million, or $0.51 per diluted share, compared ...

Blackstone Inc. (BX) is up 6.2% today. Here is some analysis on what might have caused this price movement.

Online healthcare provider Hims Hers Health ($HIMS) asked a federal judge to dismiss a lawsuit that accuses the company of ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new ...

Well, have no fear, telehealth giant Hims is here to capitalize on…er, help address your feelings of inadequacy by offering testosterone replacement therapy service. The company announced Wednesday ...

The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.

If you purchased or acquired Hims securities between August 4, 2025 and July 29, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa ...

PRNewswire/ -- ("Glancy") announced today that the class action lawsuit covers investors who bought Hims & Hers Health, ...